Wegovy is the first FDA-approved semaglutide prescription for chronic weight management, and its price tag is the single biggest obstacle between patients and the drug. Wegovy prescription cost in 2025 typically ranges from as little as $25 per month with commercial insurance and a manufacturer savings card to more than $1,300 a month for cash payers at a typical retail pharmacy. What you actually pay depends on your plan, your employer’s formulary choices, your income, and whether you qualify for Novo Nordisk’s direct-to-patient cash program. This guide lays out the current pricing landscape without sugarcoating the math. For the full picture on prescription affordability, start with our healthcare costs guide.
List Price and Cash Retail Pricing
Novo Nordisk’s wholesale acquisition cost for Wegovy is about $1,349 per monthly supply as of 2025, according to the company’s published pricing and KFF summaries. Retail cash prices at CVS, Walgreens, Walmart, and Kroger typically land between $1,350 and $1,500 after the pharmacy’s markup. Independent pharmacies occasionally price slightly lower or higher depending on contract negotiations with distributors.
Wegovy comes in five titration doses (0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg). The price is generally the same across all strengths because you get four pre-filled pens per month regardless of dose.
Wegovy Cost With Commercial Insurance
If your employer or ACA plan covers Wegovy for obesity, copays typically land in the $25-$75 range per monthly fill on Tier 2 or Tier 3 brand formularies. When combined with the Wegovy Savings Card, copays can drop to $0 for eligible commercially insured patients, up to an annual savings cap of $225 per 28-day fill and $2,700 annually in most program years.
Coverage varies wildly. Only about a quarter of large employer plans covered GLP-1s for obesity in 2024, per KFF employer benefits surveys, though that number has been creeping upward. State Medicaid coverage is patchy, and most plans exclude weight-loss indications.
Wegovy Cost Without Insurance
Uninsured patients have more options in 2025 than they did a year ago. Novo Nordisk launched NovoCare Direct, a self-pay program that sells Wegovy to eligible cash payers for $499 per month. This price applies through partnered pharmacies that ship directly to patients. The $499 figure is significantly lower than GoodRx cash prices, which typically run $1,300-$1,500 even with coupon discounts.
For patients who cannot qualify for the direct program, GoodRx, SingleCare, and WellRx coupons provide modest reductions off retail cash, usually 10-15% below sticker price.
Medicare and Medicaid Coverage
Medicare Part D historically excluded weight-loss drugs under a 2003 statute, though CMS opened limited coverage in 2024 for patients with documented cardiovascular disease, following the FDA’s updated Wegovy label. Medicare patients should check their specific Part D plan formulary. Coverage for obesity alone remains excluded for most beneficiaries. Medicaid coverage varies by state; as of 2025, only a handful of states cover Wegovy for weight management indications.
Medicare and Medicaid patients cannot use the Wegovy Savings Card because of federal anti-kickback rules.
Patient Assistance Programs
Novo Nordisk’s Patient Assistance Program provides Wegovy at no cost to uninsured patients who meet household income limits, typically at or below 400% of the federal poverty level. Eligibility requires U.S. residency, a valid prescription, and income documentation. Approval takes several weeks.
Nonprofit foundations such as NeedyMeds aggregate additional copay assistance resources, though chronic weight management is rarely funded by disease-specific foundations.
How to Lower Your Wegovy Prescription Cost
Start by verifying insurance coverage through your plan’s formulary lookup tool. If Wegovy is covered, download the Wegovy Savings Card immediately and bring it to every refill. If it is not covered, compare NovoCare Direct’s $499 cash price to GoodRx coupons at local pharmacies. Uninsured patients below 400% FPL should apply to Novo Nordisk’s PAP before paying any cash price. Patients with cardiovascular disease should ask their prescriber to document the diagnosis for potential Medicare Part D coverage under the updated label.
For related cost comparisons, see our breakdowns of GoodRx Wegovy coupons, Ozempic GoodRx pricing, and prescription costs without insurance.
Frequently Asked Questions
How much does Wegovy cost without insurance?
Cash retail prices range from about $1,350 to $1,500 per monthly supply at major U.S. pharmacies. Novo Nordisk’s NovoCare Direct program sells Wegovy to eligible uninsured patients for $499 per month, which is significantly cheaper than any retail coupon.
Does the Wegovy Savings Card really bring the price to $0?
For commercially insured patients whose plan covers Wegovy, the savings card can reduce copays to as low as $0 per 28-day fill, up to an annual cap set by Novo Nordisk. Patients whose plans do not cover Wegovy get smaller savings.
Will Medicare pay for Wegovy in 2025?
Medicare Part D now covers Wegovy for patients with documented cardiovascular disease following FDA label updates. Coverage for weight management alone remains excluded. Check your specific Part D plan formulary for details.
Is compounded semaglutide a cheaper alternative?
During past FDA-declared shortages, 503A and 503B compounding pharmacies sold compounded semaglutide at lower prices. FDA has since removed semaglutide from its shortage list, and most compounding pharmacies have stopped selling it legally.
The Bottom Line
Wegovy prescription cost is less about sticker price and more about which savings path fits your insurance situation. Commercial plan holders should combine coverage with the Wegovy Savings Card to reach near-zero copays. Uninsured patients should prioritize NovoCare Direct’s $499 price over retail GoodRx coupons. Medicare patients with cardiovascular disease now have a legitimate coverage path through Part D. Regardless of your route, verify prices and program eligibility before every refill, because terms change and an expired card can leave you paying full retail unexpectedly.